Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma (VRTX)

Market is closed
News
Has Gilead Sciences, Inc. (GILD) Become the Perfect Stock?

Has Gilead Sciences, Inc. (GILD) Become the Perfect Stock?

One thing's for sure: You'll never discover truly great investments unless you actively look for them. Let's discuss the ideal qualities of a perfect stock, then decide if Gilead Sciences, Inc.

Keep Reading →

February 11th, 2013 - News

Gilead Sciences, Inc. (GILD): Piling on the Phase 3 Data

Gilead Sciences, Inc. (GILD): Piling on the Phase 3 Data

At this point, it looks extremely likely that sofosbuvir will be approved by the FDA. Previous data, released last November, showed the drug worked in patients with genotype 2 or 3 hepatitis C virus.

Keep Reading →

February 4th, 2013 - News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)